Literature DB >> 11713757

Gene therapy using hematopoietic stem cells.

D B Kohn1.   

Abstract

While gene therapy using hematopoietic stem cells was the first area of investigation in the field, success has proven elusive. However, significant progress has been achieved recently in methods for more effective gene transfer and expression. In addition to greatly improved results using retroviral vectors, adeno-associated vectors and lentiviral vectors appear to be promising for stable transduction of hematopoietic stem cells. These advances, documented in animal transplant models, are now being applied to clinical trials.

Mesh:

Substances:

Year:  1999        PMID: 11713757

Source DB:  PubMed          Journal:  Curr Opin Mol Ther        ISSN: 1464-8431


  7 in total

Review 1.  Stem cell and precursor cell therapy.

Authors:  Jingli Cai; Mahendra S Rao
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

2.  Targeting the HIV entry, assembly and release pathways for anti-HIV gene therapy.

Authors:  Anjali Joshi; Himanshu Garg; Sherimay Ablan; Eric O Freed; Kunio Nagashima; N Manjunath; Premlata Shankar
Journal:  Virology       Date:  2011-05-06       Impact factor: 3.616

3.  Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells.

Authors:  Ronald T Mitsuyasu; Thomas C Merigan; Andrew Carr; Jerome A Zack; Mark A Winters; Cassy Workman; Mark Bloch; Jacob Lalezari; Stephen Becker; Lorna Thornton; Bisher Akil; Homayoon Khanlou; Robert Finlayson; Robert McFarlane; Don E Smith; Roger Garsia; David Ma; Matthew Law; John M Murray; Christof von Kalle; Julie A Ely; Sharon M Patino; Alison E Knop; Philip Wong; Alison V Todd; Margaret Haughton; Caroline Fuery; Janet L Macpherson; Geoff P Symonds; Louise A Evans; Susan M Pond; David A Cooper
Journal:  Nat Med       Date:  2009-02-15       Impact factor: 53.440

Review 4.  Recent advances in gene therapy for severe congenital immunodeficiency diseases.

Authors:  Robert Sokolic; Chimene Kesserwan; Fabio Candotti
Journal:  Curr Opin Hematol       Date:  2008-07       Impact factor: 3.284

5.  Phase I/II Clinical Trials Using Gene-Modified Adult Hematopoietic Stem Cells for HIV: Lessons Learnt.

Authors:  Ronald T Mitsuyasu; Jerome A Zack; Janet L Macpherson; Geoff P Symonds
Journal:  Stem Cells Int       Date:  2011-06-13       Impact factor: 5.443

6.  CCR5 as a natural and modulated target for inhibition of HIV.

Authors:  Bryan P Burke; Maureen P Boyd; Helen Impey; Louis R Breton; Jeffrey S Bartlett; Geoff P Symonds; Gero Hütter
Journal:  Viruses       Date:  2013-12-30       Impact factor: 5.048

7.  AC133+ progenitor cells as gene delivery vehicle and cellular probe in subcutaneous tumor models: a preliminary study.

Authors:  Ali M Rad; A S M Iskander; Branislava Janic; Robert A Knight; Ali S Arbab; Hamid Soltanian-Zadeh
Journal:  BMC Biotechnol       Date:  2009-03-27       Impact factor: 2.563

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.